Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $14.80.
A number of equities analysts have weighed in on IAS shares. Scotiabank assumed coverage on Integral Ad Science in a research report on Thursday, December 5th. They set a “sector perform” rating and a $10.00 price target for the company. Oppenheimer decreased their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 13th. Craig Hallum decreased their price objective on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a report on Thursday, November 14th. Finally, Piper Sandler cut their target price on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a research note on Wednesday, November 13th.
Check Out Our Latest Analysis on IAS
Insider Activity at Integral Ad Science
Hedge Funds Weigh In On Integral Ad Science
Several institutional investors and hedge funds have recently made changes to their positions in the business. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Integral Ad Science during the 2nd quarter valued at about $4,724,000. abrdn plc raised its stake in shares of Integral Ad Science by 12.5% in the third quarter. abrdn plc now owns 2,147,656 shares of the company’s stock worth $23,216,000 after purchasing an additional 237,930 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Integral Ad Science by 47.6% in the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company’s stock worth $7,756,000 after acquiring an additional 231,271 shares during the period. Invenomic Capital Management LP grew its position in Integral Ad Science by 57.4% in the 3rd quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock worth $6,327,000 after purchasing an additional 213,488 shares during the period. Finally, Rice Hall James & Associates LLC purchased a new stake in Integral Ad Science during the third quarter valued at $1,795,000. Institutional investors own 95.78% of the company’s stock.
Integral Ad Science Stock Performance
Shares of IAS opened at $10.51 on Monday. The firm has a market capitalization of $1.71 billion, a PE ratio of 52.55, a price-to-earnings-growth ratio of 1.07 and a beta of 1.46. Integral Ad Science has a 12-month low of $7.98 and a 12-month high of $17.53. The stock’s fifty day simple moving average is $10.48 and its 200-day simple moving average is $10.83. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The firm had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. During the same period in the previous year, the company posted ($0.09) earnings per share. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. As a group, research analysts predict that Integral Ad Science will post 0.26 earnings per share for the current year.
About Integral Ad Science
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Recommended Stories
- Five stocks we like better than Integral Ad Science
- What is the Australian Securities Exchange (ASX)
- Nebius Group: Market Overreaction or Real AI Disruption?
- 3 Fintech Stocks With Good 2021 Prospects
- The Best Way to Invest in Gold Is…
- How to Invest in Blue Chip Stocks
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.